Insights

Innovative Diagnostic Solutions Allergenis offers advanced food allergy testing technology that addresses the limitations of traditional blood tests and oral food challenges, providing more accurate, comprehensive, and less invasive diagnostics which can attract healthcare providers seeking reliable diagnostic tools.

Strategic Industry Partnerships The company's collaborations with telehealth firms like LifeMD and major health systems such as Mount Sinai highlight opportunities for integrating its diagnostic solutions into broader healthcare delivery and telemedicine platforms, expanding reach and patient access.

Growing Market Focus With a mission to serve over 200 million individuals affected by food allergies worldwide, Allergenis targets a large and increasing market, especially addressing the unmet needs where current testing methods show high false-positive rates and limited clarity.

Technological Leadership Utilizing cutting-edge technologies such as peptide microarray immunoassays and Luminex xMap, Allergenis is positioned as a technology leader, offering clients opportunities for advanced diagnostic testing and potential custom solutions aligned with the latest scientific developments.

Growth and Expansion With revenue in the range of one to ten million dollars and ongoing product launches like VeriMAP Peanut Diagnostic, Allergenis presents opportunities for partners looking to expand into innovative allergen detection solutions with high growth potential in the medical diagnostics sector.

AllerGenis Tech Stack

AllerGenis uses 8 technology products and services including Facebook Pixel, Concrete CMS, Font Awesome, and more. Explore AllerGenis's tech stack below.

  • Facebook Pixel
    Analytics
  • Concrete CMS
    Content Management System
  • Font Awesome
    Font Scripts
  • Google Fonts API
    Font Scripts
  • AngularJS
    Javascript Frameworks
  • React
    Javascript Frameworks
  • Piwik
    System Analytics & Monitoring
  • Google Tag Manager
    Tag Management

Media & News

AllerGenis's Email Address Formats

AllerGenis uses at least 1 format(s):
AllerGenis Email FormatsExamplePercentage
First.Last@allergenis.comJohn.Doe@allergenis.com
50%
First.Last@allergenis.comJohn.Doe@allergenis.com
50%

Frequently Asked Questions

Where is AllerGenis's headquarters located?

Minus sign iconPlus sign icon
AllerGenis's main headquarters is located at 2801 Sterling Dr, Hatfield, Pennsylvania 19440, US. The company has employees across 1 continents, including North America.

What is AllerGenis's official website and social media links?

Minus sign iconPlus sign icon
AllerGenis's official website is allergenis.com and has social profiles on LinkedInCrunchbase.

What is AllerGenis's NAICS code?

Minus sign iconPlus sign icon
AllerGenis's NAICS code is 6215 - Medical and Diagnostic Laboratories.

How many employees does AllerGenis have currently?

Minus sign iconPlus sign icon
As of October 2025, AllerGenis has approximately 12 employees across 1 continents, including North America. Key team members include Head - Strategic Partnerships And Commercial Strategy: T. V.Head Of Marketing: K. C.Head Of Marketing: K. C.. Explore AllerGenis's employee directory with LeadIQ.

What industry does AllerGenis belong to?

Minus sign iconPlus sign icon
AllerGenis operates in the Medical and Diagnostic Laboratories industry.

What technology does AllerGenis use?

Minus sign iconPlus sign icon
AllerGenis's tech stack includes Facebook PixelConcrete CMSFont AwesomeGoogle Fonts APIAngularJSReactPiwikGoogle Tag Manager.

What is AllerGenis's email format?

Minus sign iconPlus sign icon
AllerGenis's email format typically follows the pattern of First.Last@allergenis.com. Find more AllerGenis email formats with LeadIQ.

When was AllerGenis founded?

Minus sign iconPlus sign icon
AllerGenis was founded in 2017.
AllerGenis

AllerGenis

Medical and Diagnostic LaboratoriesUnited States11-50 Employees

Our mission at Allergenis is transformative: we aim to revolutionize food allergy diagnosis and management, thereby improving the quality of life for over 200 million individuals worldwide. We have already made significant strides.  

The food allergy epidemic affects 32 million Americans, including one in 13 children, and continues to present potential life-threatening reactions to this entire population.  Sadly, it has generated substantial mental, emotional and financial burdens on individuals, parents and caregivers.

While tolerance levels and subsequent reactions vary among individuals, existing food allergy testing does not identify these ranges.  Current blood-test options in the marketplace produce ambiguous and inaccurate results which lack a full spectrum view of an individual’s allergy.  The most commonly administered blood tests have as high as a 60% false-positive rate, while the gold standard tool, an oral food challenge (OFC) is costly, time-consuming, and frequently anxiety-inducing due to the risk of clinical reaction.

Allergenis is changing the food allergy diagnostic landscape.  Offering patients with more testing options and more clarity on their food allergies.

Section iconCompany Overview

Headquarters
2801 Sterling Dr, Hatfield, Pennsylvania 19440, US
NAICS Code
6215 - Medical and Diagnostic Laboratories
Founded
2017
Employees
11-50

Section iconFunding & Financials

  • $1M$10M

    AllerGenis's revenue is estimated to be in the range of $1M$10M

Section iconFunding & Financials

  • $1M$10M

    AllerGenis's revenue is estimated to be in the range of $1M$10M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.